CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended		12 Months Ended	135 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Mar. 31, 2023
Cash flows from operating activities
Net increase in net assets resulting from operations	$ 4,736,147	$ 5,222,164
Adjustments to reconcile net increase in net assets from operations to net cash used in operating activities:
Purchases of investments	(41,237,273)	(74,535,403)
Proceeds from sales and repayments of investments	5,890,813	10,008,127
Net change in unrealized depreciation on investments	4,249,642	3,721,602
Net change in unrealized depreciation on foreign currency translations	10,126
Increase in investments due to PIK	(769,954)	(330,111)
Amortization of premium and accretion of discount, net	(665,998)	(546,806)	$ (2,519,462)
Deferred tax provision	78,760	21,157
Amortization of loan structure fees	143,822	133,262
Amortization of deferred financing costs	110,150	83,670
Amortization of loan fees on SBA-guaranteed debentures	317,508	283,144
Net realized gain on investments	(34,967)	(3,458,090)
Changes in other assets and liabilities
(Increase) decrease in interest receivable	(187,420)	179,927
Decrease in other receivable		4,257
Decrease in prepaid expenses	148,414	9,959
(Decrease) increase in management fees payable	(2,592,566)	492,713
Increase (decrease) in income incentive fees payable	2,124,835	(1,000,000)
Decrease in capital gains incentive fees payable	(569,528)	(42,217)
Increase in administrative services payable	39,951	18,320
Decrease in interest payable	(3,437,073)	(2,855,244)
Decrease in related party payable	(646,393)
Decrease in unearned revenue	(47,573)	(62,731)
Increase (decrease) in income tax payable	374,460	(755,312)
(Decrease) increase in other accrued expenses and liabilities	(78,907)	482,638
Net Cash Used in Operating Activities	(32,043,024)	(62,924,974)
Cash flows from Financing Activities
Proceeds from the issuance of common stock	8,487,127	221,176		$ 287,783,492
Sales load for common stock issued	(126,303)	(3,137)
Offering costs paid for common stock issued	(72,955)	(50,369)
Stockholder distributions paid	(5,252,174)	(4,422,688)
Proceeds from SBA-guaranteed debentures		20,000,000
Financing costs paid on SBA-guaranteed debentures		(487,000)
Financing costs paid on Credit facility		(25,881)
Borrowings under Credit Facility	13,300,000	57,388,800
Repayments of Credit Facility	(14,483,900)	(29,240,000)
Net Cash Provided by Financing Activities	1,851,795	43,380,901
Net Decrease in Cash and Cash Equivalents	(30,191,229)	(19,544,073)
Cash and Cash Equivalents Balance at Beginning of Period	48,043,329	44,174,856	44,174,856
Cash and Cash Equivalents Balance at End of Period	17,852,100	24,630,783	$ 48,043,329	$ 17,852,100
Supplemental and Non-Cash Activities
Cash paid for interest expense	10,752,017	7,216,009
Income and excise tax paid	303	1,034,730
Increase in dividends payable	2,699,110	1,041,978
Increase in deferred offering costs	$ 2,700	$ 26,481